{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:28:20Z","timestamp":1767961700172,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T00:00:00Z","timestamp":1268352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00432-010-0847-2","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T13:45:24Z","timestamp":1268401524000},"page":"1881-1890","source":"Crossref","is-referenced-by-count":15,"title":["Targeting PI3K in neuroblastoma"],"prefix":"10.1007","volume":"136","author":[{"given":"Volker","family":"Spitzenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Ulm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Marone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luise","family":"R\u00f6pke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg P.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gr\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias Paul","family":"Wymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Wetzker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,12]]},"reference":[{"issue":"9","key":"847_CR1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjc.6605014","volume":"100","author":"PF Ambros","year":"2009","unstructured":"Ambros PF, Ambros IM, Brodeur GM et al (2009) International consensus for neuroblastoma molecular diagnostics: report from the international neuroblastoma risk group (INRG) biology committee. Br J Cancer 100(9):1471\u20131482","journal-title":"Br J Cancer"},{"issue":"6858","key":"847_CR2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/35101660","volume":"413","author":"M Barbier","year":"2001","unstructured":"Barbier M, Attoub S, Calvez R et al (2001) Tumour biology. Weakening link to colorectal cancer? Nature 413(6858):796","journal-title":"Nature"},{"issue":"50","key":"847_CR3","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1038\/sj.onc.1209670","volume":"25","author":"C Billottet","year":"2006","unstructured":"Billottet C, Grandage VL, Gale RE et al (2006) A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene 25(50):6648\u20136659","journal-title":"Oncogene"},{"issue":"4","key":"847_CR4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4049\/jimmunol.171.4.1623","volume":"171","author":"KU Birkenkamp","year":"2003","unstructured":"Birkenkamp KU, Coffer PJ (2003) FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol 171(4):1623\u20131629","journal-title":"J Immunol"},{"issue":"9","key":"847_CR5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm1284","volume":"11","author":"M Camps","year":"2005","unstructured":"Camps M, Ruckle T, Ji H et al (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11(9):936\u2013943","journal-title":"Nat Med"},{"issue":"2","key":"847_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2009","unstructured":"Cohn SL, Pearson AD, London WB et al (2009) The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27(2):289\u2013297","journal-title":"J Clin Oncol"},{"issue":"18","key":"847_CR7","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/sj.onc.1210918","volume":"27","author":"A Denley","year":"2008","unstructured":"Denley A, Kang S, Karst U, Vogt PK (2008) Oncogenic signaling of class I PI3K isoforms. Oncogene 27(18):2561\u20132574","journal-title":"Oncogene"},{"issue":"1","key":"847_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-4608(94)90063-9","volume":"76","author":"T Dunn","year":"1994","unstructured":"Dunn T, Praissman L, Hagag N, Viola MV (1994) ERG gene is translocated in an Ewing\u2019s sarcoma cell line. Cancer Genet Cytogenet 76(1):19\u201322","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"847_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pharmthera.2008.02.004","volume":"118","author":"E Hirsch","year":"2008","unstructured":"Hirsch E, Ciraolo E, Ghigo A, Costa C (2008) Taming the PI3K team to hold inflammation and cancer at bay. Pharmacol Ther 118(2):192\u2013205","journal-title":"Pharmacol Ther"},{"issue":"29","key":"847_CR10","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/onc.2008.40","volume":"27","author":"S Horn","year":"2008","unstructured":"Horn S, Bergholz U, Jucker M et al (2008) Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells. Oncogene 27(29):4096\u20134106","journal-title":"Oncogene"},{"issue":"12","key":"847_CR11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00262-008-0519-0","volume":"57","author":"EE Johnson","year":"2008","unstructured":"Johnson EE, Lum HD, Rakhmilevich AL et al (2008) Intratumoral immunocytokine treatment results in enhanced antitumor effects. Cancer Immunol Immunother 57(12):1891\u20131902","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"847_CR12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1073\/pnas.0510772103","volume":"103","author":"S Kang","year":"2006","unstructured":"Kang S, Denley A, Vanhaesebroeck B, Vogt PK (2006) Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci USA 103(5):1289\u20131294","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9579","key":"847_CR13","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"JM Maris","year":"2007","unstructured":"Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369(9579):2106\u20132120","journal-title":"Lancet"},{"issue":"1","key":"847_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbapap.2007.10.003","volume":"1784","author":"R Marone","year":"2008","unstructured":"Marone R, Cmiljanovic V, Giese B, Wymann MP (2008) Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 1784(1):159\u2013185","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"847_CR15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/0008-5472.CAN-06-2201","volume":"67","author":"D Opel","year":"2007","unstructured":"Opel D, Poremba C, Simon T et al (2007) Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 67(2):735\u2013745","journal-title":"Cancer Res"},{"issue":"2","key":"847_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-005-9079-8","volume":"78","author":"B Parashar","year":"2006","unstructured":"Parashar B, Shafit-Zagardo B (2006) Inhibition of human neuroblastoma in SCID mice by low-dose of selective Cox-2 inhibitor nimesulide. J Neurooncol 78(2):129\u2013134","journal-title":"J Neurooncol"},{"issue":"3","key":"847_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2004.07.017","volume":"118","author":"E Patrucco","year":"2004","unstructured":"Patrucco E, Notte A, Barberis L et al (2004) PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118(3):375\u2013387","journal-title":"Cell"},{"issue":"5670","key":"847_CR18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304(5670):554","journal-title":"Science"},{"issue":"6798","key":"847_CR19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/35022585","volume":"406","author":"T Sasaki","year":"2000","unstructured":"Sasaki T, Irie-Sasaki J, Horie Y et al (2000) Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature 406(6798):897\u2013902","journal-title":"Nature"},{"issue":"6966","key":"847_CR20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature02203","volume":"426","author":"T Sasaki","year":"2003","unstructured":"Sasaki T, Irie-Sasaki J, Horie Y et al (2003) Corrigendum: colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature 426(6966):584","journal-title":"Nature"},{"issue":"2","key":"847_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.surg.2008.04.009","volume":"144","author":"TL Sims","year":"2008","unstructured":"Sims TL, Williams RF, Ng CY et al (2008) Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease. Surgery 144(2):269\u2013275","journal-title":"Surgery"},{"issue":"12","key":"847_CR22","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.cellsig.2007.08.006","volume":"19","author":"LD Smith","year":"2007","unstructured":"Smith LD, Hickman ES, Parry RV et al (2007) PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell Signal 19(12):2528\u20132539","journal-title":"Cell Signal"},{"issue":"5224","key":"847_CR23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1126\/science.7624799","volume":"269","author":"B Stoyanov","year":"1995","unstructured":"Stoyanov B, Volinia S, Hanck T et al (1995) Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269(5224):690\u2013693","journal-title":"Science"},{"issue":"6","key":"847_CR24","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1073\/pnas.0708766105","volume":"105","author":"J Wang","year":"2008","unstructured":"Wang J, Tucker LA, Stavropoulos J et al (2008) Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor. Proc Natl Acad Sci USA 105(6):1838\u20131843","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"847_CR25","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2174\/1381612043384402","volume":"10","author":"R Wetzker","year":"2004","unstructured":"Wetzker R, Rommel C (2004) Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr Pharm Des 10(16):1915\u20131922","journal-title":"Curr Pharm Des"},{"issue":"2","key":"847_CR26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","volume":"9","author":"MP Wymann","year":"2008","unstructured":"Wymann MP, Schneiter R (2008) Lipid signalling in disease. Nat Rev Mol Cell Biol 9(2):162\u2013176","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"41","key":"847_CR27","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1038\/onc.2008.244","volume":"27","author":"L Zhao","year":"2008","unstructured":"Zhao L, Vogt PK (2008) Class I PI3K in oncogenic cellular transformation. Oncogene 27(41):5486\u20135496","journal-title":"Oncogene"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-010-0847-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0847-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:39:58Z","timestamp":1559068798000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-010-0847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s00432-010-0847-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,12]]}}}